Everolimus plus octreotide long-acting repeatable in patients with colorectal neuroendocrine tumors: A subgroup analysis of the phase III RADIANT-2 study

Daniel Castellano, Emilio Bajetta, Ashok Panneerselvam, Stephen Saletan, Walter Kocha, Thomas O'Dorisio, Lowell B. Anthony, Timothy Hobday

Research output: Contribution to journalArticlepeer-review

47 Scopus citations

Fingerprint Dive into the research topics of 'Everolimus plus octreotide long-acting repeatable in patients with colorectal neuroendocrine tumors: A subgroup analysis of the phase III RADIANT-2 study'. Together they form a unique fingerprint.

Medicine & Life Sciences